Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
39,037,773
-
Shares change
-
+3,355,686
-
Total reported value, excl. options
-
$327,514,881
-
Value change
-
+$24,184,461
-
Put/Call ratio
-
146%
-
Number of buys
-
73
-
Number of sells
-
58
-
Price
-
$8.39
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2023
As of 30 Jun 2023 Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) had 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,037,773 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Knoll Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, EAGLE ASSET MANAGEMENT INC, Laurion Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, and Verition Fund Management LLC.
This table shows 164 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.